CDC Director Brenda Fitzgerald, MD, resigned Wednesday, one day after reports that she traded tobacco stocks while heading the agency.
CDC Director Brenda Fitzgerald, MD, resigned Wednesday, one day after reports that she traded tobacco stocks while heading the agency.
"This morning Secretary Azar accepted Dr. Brenda Fitzgerald’s resignation as Director of the Centers for Disease Control and Prevention," HHS said in a statement.
The statement said she "owns certain complex financial interests" that she could not sell "in a definitive time period."
The resignation leaves the CDC without a leader in the middle of a severe flu crisis that has gripped most of the nation.
Fitzegerald was appointed last July by President Trump and was previously Georgia’s public health commissioner.
The stock was one of about a dozen new investments that Fitzgerald made after she took over the agency’s top job, according to a report in Politico on Tuesday. Besides the tobacco stocks - an obvious conflict with the CDC's mission of promoting public health - she also purchased pharmaceutical , health insurance, and food company stocks.
But before it became know that she had purchased stocks after she began her CDC position, Fitzgerald was already under fire on Capitol Hill because the complicated investments were preventing her from appearing before Congress, Politico also reported earlier his month.
Her short tenure was marked by other controversy as well. In December, a CDC budget analyst told the media that 7 banned words had to be avoided in any budget requests. Fitzgerald denied that that any words were banned.
While in Georgia, Fitzgerald's agency accepted $1 million from Coca-Cola to fight childhood obesity in the state, which set off a debate over whether a soft-drink company could or should have a role in a a related public health issue. Fitzgerald's post about the effort is still visible on the Coca-Cola website.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen